Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Clinical trial NCT03613532 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03613532

Sponsor

Jacqueline Garcia, MD

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2018-10-24

Primary completion

2026-05-05

Enrollment

102

View on ClinicalTrials.gov